These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 1808333)

  • 1. [The kinds and characteristics of recombinant human erythropoietin].
    Morio K; Koide K
    Nihon Rinsho; 1991 Dec; 49 Suppl():663-9. PubMed ID: 1808333
    [No Abstract]   [Full Text] [Related]  

  • 2. [Human recombinant erythropoietin (rH-EPO) in chronic hemodialysis patients].
    Jalil R; Vaccarezza A; Jara A; Lira P; Vial S; Serrano V
    Rev Med Chil; 1990 Jun; 118(6):629-34. PubMed ID: 1775783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of recombinant human erythropoietin on the anemia of chronic renal failure.
    Urabe A; Takaku F; Mizoguchi H; Kubo K; Ota K; Shimizu N; Tanaka K; Mimura N; Nihei H; Koshikawa S
    Int J Cell Cloning; 1988 May; 6(3):179-91. PubMed ID: 3397592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of erythropoietin (EPO) in oncology.
    Oster W; Schindel F; Heinrichs H
    Behring Inst Mitt; 1991 Dec; (90):62-8. PubMed ID: 1801692
    [No Abstract]   [Full Text] [Related]  

  • 5. Sugar coating extends half-lives and improves effectiveness of cytokine hormones.
    Koury MJ
    Trends Biotechnol; 2003 Nov; 21(11):462-4. PubMed ID: 14573355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietin therapy in renal failure.
    Paganini EP; Miller T
    Adv Intern Med; 1993; 38():223-43. PubMed ID: 8438638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin for anemia.
    Med Lett Drugs Ther; 1989 Sep; 31(801):85-6. PubMed ID: 2671624
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of the anaemia of end-stage renal disease with recombinant human erythropoietin.
    Verbeelen D; Hauglustaine D; Sennesael J
    Neth J Med; 1988 Aug; 33(1-2):60-7. PubMed ID: 3247012
    [No Abstract]   [Full Text] [Related]  

  • 9. A probable conformational difference between recombinant and urinary erythropoietins.
    Kung CK; Goldwasser E
    Proteins; 1997 May; 28(1):94-8. PubMed ID: 9144794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of recombinant human erythropoietin usage in clinical practice in the United States. Is there an optimal way to use rHuEPO?
    Besarab A; McCrea JB
    ASAIO J; 1993; 39(1):11-8. PubMed ID: 8439674
    [No Abstract]   [Full Text] [Related]  

  • 11. Anemia of chronic inflammatory arthritides: treatment with recombinant human erythropoietin.
    Birgegård G; Gudbjrönsson B; Hällgren R; Wide L
    Contrib Nephrol; 1991; 88():295-303; discussion 304-5. PubMed ID: 2040192
    [No Abstract]   [Full Text] [Related]  

  • 12. Recombinant human erythropoietin: experimental and clinical applications.
    Nielsen OJ
    Scand J Clin Lab Invest; 1991 Feb; 51(1):1-10. PubMed ID: 2020826
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of anemia in oncology. Introduction.
    Adamson JW
    Semin Oncol; 1992 Jun; 19(3 Suppl 8):1-2. PubMed ID: 1615333
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of anemia in premature infants using recombinant human erythropoietin].
    de Haas V; Raaijmaakers BC; Semmekrot BA; Kollée LA
    Ned Tijdschr Geneeskd; 1995 Apr; 139(15):773-6. PubMed ID: 7723878
    [No Abstract]   [Full Text] [Related]  

  • 15. Quality of life in end-stage renal disease patients during recombinant human erythropoietin therapy. The Canadian Erythropoietin Study Group.
    Keown PA
    Contrib Nephrol; 1991; 88():81-6; discussion 87-9. PubMed ID: 2040199
    [No Abstract]   [Full Text] [Related]  

  • 16. [Application of recombinant human erythropoietin on cardiac surgery].
    Hayashi J; Shinonaga M; Eguchi S; Shinada S
    Kokyu To Junkan; 1992 Aug; 40(8):751-7. PubMed ID: 1529171
    [No Abstract]   [Full Text] [Related]  

  • 17. Chronic anemia after lung transplantation: treatment with human recombinant erythropoietin.
    End A; Ringl H; Grimm M; Schlick W; Schreiner W; Klepetko W; Wolner E
    Transplantation; 1994 Apr; 57(7):1142. PubMed ID: 8165717
    [No Abstract]   [Full Text] [Related]  

  • 18. [Recombinant human erythropoietin in uremic patients in substitute treatment].
    Canaud B; Mion C
    Rev Prat; 1992 Feb; 42(4):432-40. PubMed ID: 1604162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin: in vitro and in vivo studies of the regulation of erythropoiesis.
    Adamson JW
    Schweiz Med Wochenschr; 1988 Oct; 118(42):1501-6. PubMed ID: 2849202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of recombinant human erythropoietin on soluble interleukin 2 receptor (SIL-2R) levels in haemodialysis patients.
    Altun B; Erdem Y; Haznedaroğlu I; Gürsoy M; Yasavul U; Turgan C; Cağlar S; Kirazli S
    Nephrol Dial Transplant; 1995 Nov; 10(11):2164. PubMed ID: 8643199
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.